Immunotherapy in Nonmelanoma Skin Cancer

被引：4
|
作者：
Bassas Freixas, P. [1 ]
Aparicio Espanol, G. [1 ]
Garcia-Patos Briones, V [1 ]
机构：
[1] Hosp Univ Vail dHebron, Serv Dermatol, Barcelona, Spain
来源：
ACTAS DERMO-SIFILIOGRAFICAS | 2019年 / 110卷 / 05期
关键词：
Nonmelanoma skin cancer; Immunotherapy; Programmed cell death protein 1 (PD-1); Programmed death ligand 1 (PD-L1); Cytotoxic T-lymphocyte-associated antigen 4 (CTLA-4); SQUAMOUS-CELL CARCINOMA; LONG-TERM SURVIVAL; DEATH LIGAND; IPILIMUMAB; EXPRESSION; PEMBROLIZUMAB; REGRESSION; BLOCKADE; CTLA-4; PD-L2;
D O I：
10.1016/j.ad.2018.09.013
中图分类号：
R75 [皮肤病学与性病学];
学科分类号：
100206 ;
摘要：
Immunotherapy is emerging as a new and promising treatment for a great variety of tumors, including nonmelanoma skin cancer. Checkpoint inhibitors - antibodies that block proteins that regulate the immune system - mainly target the surface protein CTLA-4 (cytotoxic T-lymphocyte-associated antigen 4) and the PD-1/PD-L1 (programmed cell death protein 1/PD-ligand 1) axis. We review the CTLA-4 and PD-1/PD-L1 pathways and current evidence supporting checkpoint inhibitor therapy in the main types of nonmelanoma skin cancer. (C) 2018 AEDV. Published by Elsevier Espana, S.L.U. All rights reserved.
引用
收藏
页码：353 / 359
页数：7
相关论文
共 50 条
  • [1] Immunotherapy in nonmelanoma skin cancer
    Ghafouri-Fard, Soudeh
    Ghafouri-Fard, Somayyeh
    IMMUNOTHERAPY, 2012, 4 (05) : 499 - 510
  • [2] Immunotherapy for Nonmelanoma Skin Cancer: Facts and Hopes
    Shalhout, Sophia Z.
    Kaufman, Howard L.
    Emerick, Kevin S.
    Miller, David M.
    CLINICAL CANCER RESEARCH, 2022, 28 (11) : 2211 - 2220
  • [3] Targeted Therapy and Immunotherapy in Nonmelanoma Skin Cancer
    Aboul-Fettouh, Nader
    Kubicki, Shelby L.
    Chen, Leon
    Silapunt, Sirunya
    Migden, Michael R.
    DERMATOLOGIC CLINICS, 2023, 41 (01) : 23 - 37
  • [4] Immunotherapy for nonmelanoma skin cancer - Does it have a future?
    Urosevic, M
    Dummer, R
    CANCER, 2002, 94 (02) : 477 - 485
  • [5] Society for Immunotherapy of Cancer (SITC) clinical practice guideline on immunotherapy for the treatment of nonmelanoma skin cancer
    Silk, Ann W.
    Barker, Christopher A.
    Bhatia, Shailender
    Bollin, Kathryn B.
    Chandra, Sunandana
    Eroglu, Zeynep
    Gastman, Brian R.
    Kendra, Kari L.
    Kluger, Harriet
    Lipson, Evan J.
    Madden, Kathleen
    Miller, David M.
    Nghiem, Paul
    Pavlick, Anna C.
    Puzanov, Igor
    Rabinowits, Guilherme
    Ruiz, Emily S.
    Sondak, Vernon K.
    Tavss, Edward A.
    Tetzlaff, Michael T.
    Brownell, Isaac
    JOURNAL FOR IMMUNOTHERAPY OF CANCER, 2022, 10 (07)
  • [6] Nonmelanoma Skin Cancer
    Brandt, Michael G.
    Moore, Corey C.
    FACIAL PLASTIC SURGERY CLINICS OF NORTH AMERICA, 2019, 27 (01) : 1 - +
  • [7] Nonmelanoma skin cancer
    Acartürk, TO
    Edington, H
    CLINICS IN PLASTIC SURGERY, 2005, 32 (02) : 237 - +
  • [8] Nonmelanoma skin cancer
    Skidmore, RA
    Flowers, FP
    MEDICAL CLINICS OF NORTH AMERICA, 1998, 82 (06) : 1309 - +
  • [9] Nonmelanoma Skin Cancer
    Dubas, Lauren E.
    Ingraffea, Adam
    FACIAL PLASTIC SURGERY CLINICS OF NORTH AMERICA, 2013, 21 (01) : 43 - +
  • [10] Nonmelanoma skin cancer
    Ridky, Todd W.
    JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2007, 57 (03) : 484 - 501
12345